News
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...
Results come after positive results from a trial among people with idiopathic pulmomary disease.
A panelist discusses how the POD1UM-303 randomized phase 3 trial demonstrated that adding retifanlimab (a PD-1 inhibitor) to ...
A panelist discusses how the most effective therapy for squamous cell anal carcinoma is prevention through human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback